CLOSE X

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2228.0081.3 (+3.79 %)
PREV CLOSE ( ) 2146.70
OPEN PRICE ( ) 2102.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1043
TODAY'S LOW / HIGH ( )2102.60 2254.95
52 WK LOW / HIGH ( )985.05 2596
NSE2223.5090.9 (+4.26 %)
PREV CLOSE( ) 2132.60
OPEN PRICE ( ) 2128.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2223.50 (279)
VOLUME 4949
TODAY'S LOW / HIGH( ) 2100.40 2255.80
52 WK LOW / HIGH ( )980 2575
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981
Management Info
Dhananjay Mungale - Chairman Rahul Nachane - Managing Director
Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE
NEWS
13Mar NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obl..
03Jan NGL Fine-Chem informs about certifica
Based on the confirmation received from Purva Sharegistry (I), Registrar..
25Jul NGL Fine-Chem submits BRSR
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of..
10Jul NGL Fine Chem informs about compliance
NGL Fine Chem has informed that it enclosed compliance certificate under..
27Jun NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
Financials
in Crores
QTR Dec 25 ANNUAL 25
Net Profit14.7418.13
Gross Profit 19.37 23.88
Operating Profit 24.7835.46
Net Sales 126.33359.29
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  13225.55 (6.36%)
M.Cap ( in Cr)16968.23
Acutaas Chemicals (BSE)
up  2214.90 (4.92%)
M.Cap ( in Cr)18133.63
Sanofi India (BSE)
up  3349.40 (2.58%)
M.Cap ( in Cr)7713.88
Sanofi Cons. Health (BSE)
up  4644.60 (1.64%)
M.Cap ( in Cr)10696.80
Procter&Gamble Healt (BSE)
up  4810.15 (0.83%)
M.Cap ( in Cr)7984.55
Shareholding Pattern
PROMOTERS 72.74%
NON-INSTITUTION 27.26%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
Bandhan BSE Healthcare Index Fund-Reg(G)0.01
Motilal Oswal BSE Healthcare ETF0.01
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.